142 related articles for article (PubMed ID: 18367323)
1. Transforming growth factor beta suppresses beta-catenin/Wnt signaling and stimulates an adhesion response in human colon carcinoma cells in a Smad4/DPC4 independent manner.
Wang H; Rajan S; Liu G; Chakrabarty S
Cancer Lett; 2008 Jun; 264(2):281-7. PubMed ID: 18367323
[TBL] [Abstract][Full Text] [Related]
2. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
[TBL] [Abstract][Full Text] [Related]
3. Smad4 restoration leads to a suppression of Wnt/beta-catenin signaling activity and migration capacity in human colon carcinoma cells.
Tian X; Du H; Fu X; Li K; Li A; Zhang Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):478-83. PubMed ID: 19284991
[TBL] [Abstract][Full Text] [Related]
4. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways.
Labbé E; Letamendia A; Attisano L
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8358-63. PubMed ID: 10890911
[TBL] [Abstract][Full Text] [Related]
5. The murine gastrin promoter is synergistically activated by transforming growth factor-beta/Smad and Wnt signaling pathways.
Lei S; Dubeykovskiy A; Chakladar A; Wojtukiewicz L; Wang TC
J Biol Chem; 2004 Oct; 279(41):42492-502. PubMed ID: 15292219
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 induces proliferation in colon carcinoma cells by Ras-dependent, smad-independent down-regulation of p21cip1.
Yan Z; Kim GY; Deng X; Friedman E
J Biol Chem; 2002 Mar; 277(12):9870-9. PubMed ID: 11784716
[TBL] [Abstract][Full Text] [Related]
7. Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300.
Hirota M; Watanabe K; Hamada S; Sun Y; Strizzi L; Mancino M; Nagaoka T; Gonzales M; Seno M; Bianco C; Salomon DS
Cell Signal; 2008 Sep; 20(9):1632-41. PubMed ID: 18595660
[TBL] [Abstract][Full Text] [Related]
8. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
9. Requirement of cell cycle and apoptosis regulator 1 for target gene activation by Wnt and beta-catenin and for anchorage-independent growth of human colon carcinoma cells.
Ou CY; Kim JH; Yang CK; Stallcup MR
J Biol Chem; 2009 Jul; 284(31):20629-37. PubMed ID: 19520846
[TBL] [Abstract][Full Text] [Related]
10. Functional blockade of Smad4 leads to a decrease in beta-catenin levels and signaling activity in human pancreatic carcinoma cells.
Romero D; Iglesias M; Vary CP; Quintanilla M
Carcinogenesis; 2008 May; 29(5):1070-6. PubMed ID: 18310088
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between TGFβ and Wnt signaling pathways in the human trabecular meshwork.
Webber HC; Bermudez JY; Sethi A; Clark AF; Mao W
Exp Eye Res; 2016 Jul; 148():97-102. PubMed ID: 27091054
[TBL] [Abstract][Full Text] [Related]
12. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
[TBL] [Abstract][Full Text] [Related]
13. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
14. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells.
Chen WB; Lenschow W; Tiede K; Fischer JW; Kalthoff H; Ungefroren H
J Biol Chem; 2002 Sep; 277(39):36118-28. PubMed ID: 12140283
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta responsiveness in DPC4/SMAD4-null cancer cells.
Dai JL; Schutte M; Bansal RK; Wilentz RE; Sugar AY; Kern SE
Mol Carcinog; 1999 Sep; 26(1):37-43. PubMed ID: 10487520
[TBL] [Abstract][Full Text] [Related]
16. TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells.
Chow JY; Cabral JA; Chang J; Carethers JM
Cancer Biol Ther; 2008 Oct; 7(10):1694-9. PubMed ID: 18769113
[TBL] [Abstract][Full Text] [Related]
17. DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression.
Schwarte-Waldhoff I; Klein S; Blass-Kampmann S; Hintelmann A; Eilert C; Dreschers S; Kalthoff H; Hahn SA; Schmiegel W
Oncogene; 1999 May; 18(20):3152-8. PubMed ID: 10340387
[TBL] [Abstract][Full Text] [Related]
18. Curcumin and emodin down-regulate TGF-β signaling pathway in human cervical cancer cells.
Thacker PC; Karunagaran D
PLoS One; 2015; 10(3):e0120045. PubMed ID: 25786122
[TBL] [Abstract][Full Text] [Related]
19. Examining Crosstalk among Transforming Growth Factor β, Bone Morphogenetic Protein, and Wnt Pathways.
Coster AD; Thorne CA; Wu LF; Altschuler SJ
J Biol Chem; 2017 Jan; 292(1):244-250. PubMed ID: 27895117
[TBL] [Abstract][Full Text] [Related]
20. The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways.
Guo W; Flanagan J; Jasuja R; Kirkland J; Jiang L; Bhasin S
J Biol Chem; 2008 Apr; 283(14):9136-45. PubMed ID: 18203713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
